financetom
Business
financetom
/
Business
/
ClearPoint Neuro Names Paul Larson as Chief Medical Officer
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ClearPoint Neuro Names Paul Larson as Chief Medical Officer
Sep 25, 2025 1:54 PM

04:20 PM EDT, 09/25/2025 (MT Newswires) -- ClearPoint Neuro ( CLPT ) said late Thursday it named Paul Larson as chief medical officer, starting January 2026.

Larson will continue to work at the University of California San Francisco and at Banner Hospital, University of Arizona to enroll patients in cell and gene therapy clinical trials, the company said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Anterix Q1 net income beats analyst expectations
Anterix Q1 net income beats analyst expectations
Aug 12, 2025
Overview * Anterix ( ATEX ) fiscal Q1 net income $25.18 mln, beats analyst expectations, per LSEG data * EPS for fiscal Q1 was $1.35, beating analyst expectations, per LSEG data * Co recorded gains from exchange and sale of broadband licenses Outlook * Company expects $70 mln in contracted proceeds for remainder of fiscal 2026 * Anterix ( ATEX...
CoreWeave Q2 Loss Narrows, Revenue Rises
CoreWeave Q2 Loss Narrows, Revenue Rises
Aug 12, 2025
04:15 PM EDT, 08/12/2025 (MT Newswires) -- CoreWeave ( CRWV ) reported a Q2 loss late Tuesday of $0.60 per diluted share, narrowing from a loss of $1.62 a year earlier. Analysts polled by FactSet expected a GAAP loss of $0.52. Revenue for the quarter ended June 30 was $1.21 billion, up from $395.4 million a year earlier. Analysts surveyed...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Editas Medicine posts Q2 net loss of $53.2 mln
Editas Medicine posts Q2 net loss of $53.2 mln
Aug 12, 2025
Overview * Editas Q2 net loss at $53.2 mln, missing analyst expectations * Collaboration and R&D revenues rise significantly due to milestone payments * Operating expenses decrease following reni-cel program discontinuation Outlook * Company plans to file IND by mid-2026 * Company expects cash runway into Q2 2027 Result Drivers * COLLABORATION REVENUE - Increase in collaboration and R&D revenues...
Copyright 2023-2026 - www.financetom.com All Rights Reserved